Stockreport

Novo Nordisk stock soars after FDA approves first oral GLP-1 for weight loss [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Food and Drug Administration approved the company's Wegovy pill as the first oral GLP-1 receptor agonist for weight management. The once-daily oral semaglutide 25 mg p [Read more]